As of the end of September, LIVZON PHARMA has repurchased a total of 15.3768 million A shares
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, LIVZON PHARMA announced that as of September 30, 2025, the company repurchased a total of 15.3768 million A-shares through centralized bidding, accounting for 1.70% of the company's total share capital. The highest purchase price was RMB 41.99 per share, and the lowest price was RMB 33.21 per share, with a total amount of funds used being RMB 570 million (excluding transaction fees). The above repurchase is in line with the company's established share repurchase plan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments